Literature DB >> 2650520

Atherosclerosis and aging: a scenario in flux.

W R Hazzard1.   

Abstract

Atherosclerosis is an age-related process that reflects the interaction between aging per se (primary aging) and factors that influence the rate of atherogenesis. Some of the latter are physiologic, notably sex steroid levels and possibly changes in adiposity, whereas others are modulated by diet and other aspects of lifestyle, such as cigarette smoking and hypertension. Recent declines in atherosclerotic disease suggest that the rate of atherogenesis is amenable to both changes in lifestyle and effective pharmacologic management of risk factors, deferring the onset of clinical disease until late in life or preventing its emergence altogether.

Entities:  

Mesh:

Year:  1989        PMID: 2650520     DOI: 10.1016/0002-9149(89)90111-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

2.  Plasma kinetics of a cholesterol-rich emulsion in young, middle-aged, and elderly subjects.

Authors:  L B Pinto; M Wajngarten; E L Silva; C C Vinagre; R C Maranhão
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

3.  Acute coronary syndrome in the older adults.

Authors:  Xuming Dai; Jan Busby-Whitehead; Karen P Alexander
Journal:  J Geriatr Cardiol       Date:  2016-02       Impact factor: 3.327

4.  Age-associated downregulation of vasohibin-1 in vascular endothelial cells.

Authors:  Eichi Takeda; Yasuhiro Suzuki; Yasufumi Sato
Journal:  Aging Cell       Date:  2016-06-21       Impact factor: 9.304

Review 5.  Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity.

Authors:  Yasufumi Sato
Journal:  J Atheroscler Thromb       Date:  2018-02-03       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.